Previous 10 | Next 10 |
CytoSorbents ( NASDAQ: CTSO ) said the Israeli Ministry of Health approved national reimbursement for CytoSorb in certain cardiac surgery indications which is expected to take effect in 2023. The company added that once the policy revision is completed, public hospital...
Israeli Ministry of Health Approves National Coverage for CytoSorb® PR Newswire PRINCETON, N.J. , Aug. 17, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive car...
Cytosorbents Corporation (CTSO) Q2 2022 Earnings Conference Call August 2, 2022 4:30 PM ET Company Participants Amy Vogel – Investor Relations Phillip Chan – Chief Executive Officer Kathleen Bloch – Chief Financial Officer Christian Stein...
Cytosorbents press release ( NASDAQ: CTSO ): Q2 GAAP EPS of -$0.25 misses by $0.13 . Revenue of $8.5M (-29.3% Y/Y) misses by $1.06M . For further details see: Cytosorbents GAAP EPS of -$0.25 misses by $0.13, revenue of $8.5M misses by $1.06M
CytoSorb® Becomes a Featured Blood Purification Therapy on Fresenius Medical Care Critical Care Platforms PR Newswire Fresenius Medical Care and CytoSorbents have expanded their partnership via a multi-stage collaboration designed to seize new sales opportunitie...
CytoSorbents Reports Second Quarter 2022 Financial and Operational Results PR Newswire PRINCETON, N.J. , Aug. 2, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensiv...
CytoSorbents to Report Second Quarter 2022 Operating and Financial Results PR Newswire PRINCETON, N.J. , July 25, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive c...
The 2022 CytoSorb World Users' Meeting Highlights the Broad Market Potential of CytoSorb as an Interdisciplinary Therapeutic Approach PR Newswire PRINCETON, N.J. and BERLIN , July 8, 2022 /PRNewswire/ -- During the recent 2022 CytoSorb Users' Meetin...
Leading Critical Care and Cardiac Surgery Specialists from 40 Countries Meet to Discuss CytoSorb and the New Dimension in Blood Purification PR Newswire The 2022 CytoSorb World Users' Meeting focuses on groundbreaking new applications of the adsorption technology to ce...
The following slide deck was published by Cytosorbents Corporation in conjunction with this event. For further details see: Cytosorbents (CTSO) 2022 Annual Shareholders Meeting - Slideshow
News, Short Squeeze, Breakout and More Instantly...
CytoSorbents Corporation Company Name:
CTSO Stock Symbol:
NASDAQ Market:
CytoSorbents Corporation Website:
PRINCETON, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of deadly conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces that it has regained comp...
PRINCETON, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of deadly conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, is proud to announce the launch of ...
PRINCETON, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces it will present...